Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C024709 |
2,6-di-tert-butyl-4-methylene-2,5-cyclohexadienone |
2,6-di-tert-butyl-4-methylene-2,5-cyclohexadienone binds to EEF2 protein | affects binding | 16533022
|
C019499 |
2-nitrofluorene |
2-nitrofluorene results in increased expression of EEF2 mRNA | increases expression | 15890375
|
C472791 |
3-(4'-hydroxy-3'-adamantylbiphenyl-4-yl)acrylic acid |
3-(4'-hydroxy-3'-adamantylbiphenyl-4-yl)acrylic acid results in decreased expression of EEF2 mRNA | decreases expression | 12958071
|
C027576 |
4-hydroxy-2-nonenal |
4-hydroxy-2-nonenal results in decreased expression of EEF2 protein | decreases expression | 16469450
|
C016583 |
4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone |
4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of EEF2 mRNA | increases expression | 15890375
|
C010643 |
6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid |
6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid inhibits the reaction [cumene hydroperoxide results in decreased expression of EEF2 protein] | decreases expression|decreases reaction | 17510559
|
C010643 |
6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid |
6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid results in increased expression of EEF2 protein | increases expression | 17510559
|
D000079 |
Acetaldehyde |
Acetaldehyde results in decreased expression of EEF2 protein | decreases expression | 16469450
|
D000082 |
Acetaminophen |
Acetaminophen affects the expression of EEF2 mRNA | affects expression | 17562736
|
D016604 |
Aflatoxin B1 |
Aflatoxin B1 results in increased expression of EEF2 mRNA | increases expression | 15890375
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of EEF2 mRNA | affects expression | 16483693
|
D003913 |
Dextroamphetamine |
Dextroamphetamine results in decreased expression of EEF2 mRNA | decreases expression | 12558987
|
C006632 |
arsenic trioxide |
arsenic trioxide results in decreased expression of EEF2 protein | decreases expression | 19364129
|
D001280 |
Atrazine |
[Atrazine co-treated with Diuron co-treated with isoproturon] results in increased expression of EEF2 mRNA | affects cotreatment|increases expression | 15654877
|
D001280 |
Atrazine |
[Atrazine co-treated with Diuron co-treated with isoproturon] results in decreased expression of EEF2 mRNA | affects cotreatment|decreases expression | 16532367
|
D001554 |
Benzene |
Benzene affects the expression of EEF2 mRNA | affects expression | 15878777
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in increased expression of EEF2 mRNA | increases expression | 20440473
|
D020122 |
tert-Butylhydroperoxide |
tert-Butylhydroperoxide results in decreased expression of EEF2 protein | decreases expression | 16469450
|
D002118 |
Calcium |
[Calcium co-treated with Calcitriol] affects the expression of EEF2 mRNA | affects cotreatment|affects expression | 15913539
|
C099555 |
CD 437 |
CD 437 results in decreased expression of EEF2 mRNA | decreases expression | 12958071
|
D002509 |
Cephaloridine |
Cephaloridine results in increased expression of EEF2 mRNA | increases expression | 18172885
|
D002713 |
Chlorine |
[Ozone co-treated with Chlorine] results in decreased expression of EEF2 mRNA | affects cotreatment|decreases expression | 18636392
|
C074702 |
chromium hexavalent ion |
chromium hexavalent ion results in decreased expression of EEF2 mRNA | decreases expression | 15003702
|
C023600 |
chromium oxide |
chromium oxide results in decreased expression of EEF2 mRNA | decreases expression | 15003702
|
C007164 |
cumene hydroperoxide |
6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid inhibits the reaction [cumene hydroperoxide results in decreased expression of EEF2 protein] | decreases expression|decreases reaction | 17510559
|
C007164 |
cumene hydroperoxide |
cumene hydroperoxide results in decreased expression of EEF2 protein | decreases expression | 16469450 17510559
|
C007164 |
cumene hydroperoxide |
Vitamin E analog inhibits the reaction [cumene hydroperoxide results in decreased expression of EEF2 protein] | decreases expression|decreases reaction | 17510559
|
D003520 |
Cyclophosphamide |
Cyclophosphamide results in decreased expression of EEF2 mRNA | decreases expression | 18246545
|
D016572 |
Cyclosporine |
Cyclosporine results in increased expression of EEF2 mRNA | increases expression | 20106945
|
D004054 |
Diethylstilbestrol |
Diethylstilbestrol results in increased expression of EEF2 mRNA | increases expression | 15890375
|
D002117 |
Calcitriol |
[Calcium co-treated with Calcitriol] affects the expression of EEF2 mRNA | affects cotreatment|affects expression | 15913539
|
D004128 |
Dimethylnitrosamine |
Dimethylnitrosamine results in increased expression of EEF2 mRNA | increases expression | 15890375
|
D004237 |
Diuron |
[Atrazine co-treated with Diuron co-treated with isoproturon] results in increased expression of EEF2 mRNA | affects cotreatment|increases expression | 15654877
|
D004237 |
Diuron |
[Atrazine co-treated with Diuron co-treated with isoproturon] results in decreased expression of EEF2 mRNA | affects cotreatment|decreases expression | 16532367
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in increased expression of EEF2 mRNA | increases expression | 17942748
|
D004997 |
Ethinyl Estradiol |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of EEF2 mRNA | affects cotreatment|increases expression | 17942748
|
D019833 |
Genistein |
Genistein results in decreased expression of EEF2 mRNA | decreases expression | 16705744
|
D018684 |
Glycine Agents |
Glycine Agents results in increased expression of EEF2 mRNA | increases expression | 16532367
|
C001654 |
hyperforin |
hyperforin affects the expression of EEF2 protein | affects expression | 15095150
|
C028904 |
isoproturon |
[Atrazine co-treated with Diuron co-treated with isoproturon] results in increased expression of EEF2 mRNA | affects cotreatment|increases expression | 15654877
|
C028904 |
isoproturon |
[Atrazine co-treated with Diuron co-treated with isoproturon] results in decreased expression of EEF2 mRNA | affects cotreatment|decreases expression | 16532367
|
D008315 |
Malondialdehyde |
Malondialdehyde results in decreased expression of EEF2 protein | decreases expression | 16469450
|
D008701 |
Methapyrilene |
Methapyrilene results in increased expression of EEF2 mRNA | increases expression | 15890375
|
D008767 |
Methylmercury Compounds |
Methylmercury Compounds results in increased expression of EEF2 mRNA | increases expression | 16966085
|
D015741 |
Metribolone |
Metribolone promotes the reaction [NDRG1 protein binds to EEF2 protein] | affects binding|increases reaction | 17220478
|
D015741 |
Metribolone |
Metribolone results in increased expression of EEF2 protein | increases expression | 17152098
|
D010126 |
Ozone |
[Ozone co-treated with Chlorine] results in decreased expression of EEF2 mRNA | affects cotreatment|decreases expression | 18636392
|
C058305 |
phenethyl isothiocyanate |
phenethyl isothiocyanate results in decreased expression of EEF2 mRNA | decreases expression | 17616710
|
D010882 |
Piperonyl Butoxide |
Piperonyl Butoxide results in increased expression of EEF2 mRNA | increases expression | 15890375
|
C006253 |
pirinixic acid |
pirinixic acid results in increased expression of EEF2 mRNA | increases expression | 15890375
|
C037219 |
quinoline |
quinoline analog results in decreased expression of EEF2 protein | decreases expression | 18645022
|
C059514 |
resveratrol |
resveratrol results in increased phosphorylation of EEF2 protein | increases phosphorylation | 18562309
|
C085746 |
rottlerin |
rottlerin results in decreased phosphorylation of EEF2 protein | decreases phosphorylation | 12720544
|
D018038 |
Sodium Selenite |
Sodium Selenite results in increased expression of EEF2 mRNA | increases expression | 18175754
|
D013749 |
Tetrachlorodibenzodioxin |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of EEF2 mRNA | affects cotreatment|increases expression | 17942748
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of EEF2 protein | decreases expression | 16548065
|
D014810 |
Vitamin E |
Vitamin E analog inhibits the reaction [cumene hydroperoxide results in decreased expression of EEF2 protein] | decreases expression|decreases reaction | 17510559
|
D014810 |
Vitamin E |
Vitamin E analog results in increased expression of EEF2 protein | increases expression | 17510559
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
2.35 | 15322242 14514962 11752688 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.05 | 18287403 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
3.42 | 17505938 |
MESH:D058186 |
Acute Kidney Injury |
|
resveratrol |
3.40 | 16538975 |
MESH:D055371 |
Acute Lung Injury |
|
Chlorine |
7.60 | 20601635 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
7.60 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
arsenic trioxide |
11.87 | 19825857 11798837 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
11.87 | 20464547 20127859 |
MESH:D000230 |
Adenocarcinoma |
|
Dimethylnitrosamine |
11.87 | 16033868 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
11.87 | 14692618 |
MESH:D000230 |
Adenocarcinoma |
|
Genistein |
11.87 | 11473722 |
MESH:D000236 |
Adenoma |
|
4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone |
13.51 | 16176798 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
13.51 | 6695378 |
MESH:D000236 |
Adenoma |
|
Dimethylnitrosamine |
13.51 | 19555203 |
MESH:D000236 |
Adenoma |
|
resveratrol |
13.51 | 15688382 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
8.22 | 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
8.22 | 16835633 |
MESH:D000382 |
Agricultural Workers' Diseases |
|
Atrazine |
3.73 | 11874814 |
MESH:D000544 |
Alzheimer Disease |
|
Ozone |
3.91 | 15513908 |
MESH:D000544 |
Alzheimer Disease |
|
resveratrol |
3.91 | 16162502 16183991 |
MESH:D000686 |
Amyloidosis |
|
Diethylstilbestrol |
4.00 | 15469931 |
MESH:D000690 |
Amyotrophic Lateral Sclerosis |
|
4-hydroxy-2-nonenal |
3.77 | 10965797 |
MESH:D000740 |
Anemia |
|
Malondialdehyde |
7.90 | 17278206 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
7.90 | 11748828 |
MESH:D000741 |
Anemia, Aplastic |
|
Benzene |
3.97 | 14761424 17661222 11369114 |
MESH:D000799 |
Angioedema |
|
Acetaminophen |
3.33 | 10982225 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
3.58 | 19183758 |
MESH:D001161 |
Arteriosclerosis |
|
Cyclophosphamide |
8.53 | 15014928 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
8.53 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
6.27 | 15885639 |
MESH:D001169 |
Arthritis, Experimental |
|
resveratrol |
6.27 | 17115116 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Ozone |
2.42 | 15570426 |
MESH:D001249 |
Asthma |
|
Acetaldehyde |
4.83 | 9600491 |
MESH:D001249 |
Asthma |
|
Ozone |
4.83 | 16373670 17854713 |
MESH:D050197 |
Atherosclerosis |
|
resveratrol |
2.96 | 16873680 17967414 |
MESH:D001321 |
Autistic Disorder |
|
Acetaminophen |
1.48 | 18445737 |
MESH:D001778 |
Blood Coagulation Disorders |
|
arsenic trioxide |
12.65 | 16206674 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
12.65 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
12.65 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.27 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.43 | 15746008 |
MESH:D001855 |
Bone Marrow Diseases |
|
Benzene |
4.71 | 16183116 |
MESH:D002545 |
Brain Ischemia |
|
resveratrol |
3.78 | 17600658 |
MESH:D001943 |
Breast Neoplasms |
marker/mechanism |
|
| 20562527 |
MESH:D001943 |
Breast Neoplasms |
|
4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone |
5.18 | 20146248 |
MESH:D001943 |
Breast Neoplasms |
|
Benzene |
5.18 | 11921183 17162533 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
5.18 | 20146248 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Calcitriol |
5.18 | 11237771 |
MESH:D001943 |
Breast Neoplasms |
|
Cyclophosphamide |
5.18 | 15093573 16978400 18234424 12006526 11325840 17388661 17020986 15136595 18323546 |
MESH:D001943 |
Breast Neoplasms |
|
Diethylstilbestrol |
5.18 | 15324884 17129689 |
MESH:D001943 |
Breast Neoplasms |
|
Genistein |
5.18 | 17200150 16873071 16541309 |
MESH:D001943 |
Breast Neoplasms |
|
resveratrol |
5.18 | 17651959 16393696 17534123 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
5.18 | 20435547 |
MESH:D016535 |
Bronchial Hyperreactivity |
|
Ozone |
3.28 | 18315731 17626835 15516495 14754758 18417511 19059883 16777450 |
MESH:D002051 |
Burkitt Lymphoma |
|
arsenic trioxide |
3.86 | 11589617 |
MESH:D002100 |
Cachexia |
|
Ozone |
4.23 | 16183385 |
MESH:D002252 |
Carbon Tetrachloride Poisoning |
|
Vitamin E |
3.44 | 16050911 |
MESH:D002277 |
Carcinoma |
|
Dimethylnitrosamine |
7.01 | 19555203 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
7.01 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Acetaminophen |
15.06 | 3084413 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Aflatoxin B1 |
15.06 | 12907637 12619106 21507988 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
arsenic trioxide |
15.06 | 14691202 15553829 16217749 11135700 15073043 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Cyclophosphamide |
15.06 | 19701751 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Diethylstilbestrol |
15.06 | 16924424 15948411 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Genistein |
15.06 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
quinoline |
15.06 | 598648 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
resveratrol |
15.06 | 16227395 19321006 |
MESH:D018827 |
Carcinoma, Lewis Lung |
|
Cyclophosphamide |
9.80 | 16152834 |
MESH:D018827 |
Carcinoma, Lewis Lung |
|
resveratrol |
9.80 | 16675471 |
MESH:D002291 |
Carcinoma, Papillary |
|
arsenic trioxide |
4.36 | 19014326 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Cyclophosphamide |
3.28 | 16201981 |
MESH:D018288 |
Carcinoma, Small Cell |
|
arsenic trioxide |
3.67 | 12490120 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
9.38 | 20419170 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Calcitriol |
9.38 | 11237771 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Dimethylnitrosamine |
9.38 | 16033868 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
resveratrol |
9.38 | 16227395 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.07 | 16120746 18670907 18850075 |
MESH:D002310 |
Cardiomyopathy, Alcoholic |
|
Acetaldehyde |
5.96 | 10525098 |
MESH:D002318 |
Cardiovascular Diseases |
|
Genistein |
6.32 | 16332659 |
MESH:D002318 |
Cardiovascular Diseases |
|
resveratrol |
6.32 | 15458977 |
MESH:D002386 |
Cataract |
|
Acetaminophen |
2.27 | 10977129 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
2.18 | 12371664 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
2.73 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
11.13 | 19486331 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
11.13 | 16919318 17110522 17681005 11677210 16105132 15861022 17333356 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
11.13 | 19176532 |
MESH:D019457 |
Chromosome Breakage |
|
Sodium Selenite |
4.25 | 15894690 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
1.87 | 15668235 15340226 12621046 8697196 16354765 |
MESH:D003092 |
Colitis |
|
resveratrol |
3.64 | 16474422 |
MESH:D003093 |
Colitis, Ulcerative |
|
phenethyl isothiocyanate |
3.46 | 20423518 |
MESH:D003110 |
Colonic Neoplasms |
|
Genistein |
3.55 | 17182828 |
MESH:D003110 |
Colonic Neoplasms |
|
resveratrol |
3.55 | 16338953 |
MESH:D015179 |
Colorectal Neoplasms |
|
arsenic trioxide |
2.48 | 20501625 |
MESH:D015179 |
Colorectal Neoplasms |
|
resveratrol |
2.48 | 16550006 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
2.63 | 17141729 14669216 |
MESH:D003327 |
Coronary Disease |
|
resveratrol |
3.41 | 16507316 |
MESH:D023903 |
Coronary Restenosis |
|
arsenic trioxide |
3.70 | 12609071 |
MESH:D019465 |
Craniofacial Abnormalities |
|
arsenic trioxide |
4.83 | 10525206 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Benzene |
4.83 | 15643154 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
4.83 | 10048152 20055451 15322242 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Vitamin E |
4.83 | 19769572 |
MESH:D003456 |
Cryptorchidism |
|
Diethylstilbestrol |
4.07 | 12952375 16002989 |
MESH:D003556 |
Cystitis |
|
Cyclophosphamide |
4.47 | 10498854 18483878 18372110 16651033 12388444 10700343 16989017 18295254 16614059 12161096 16413132 18710439 18093676 11948286 18433785 17010015 12913760 17979934 15276878 15643279 |
MESH:D016757 |
Death, Sudden, Cardiac |
|
arsenic trioxide |
3.63 | 15213294 |
MESH:D003704 |
Dementia |
|
Methylmercury Compounds |
4.54 | 16140633 |
MESH:D003872 |
Dermatitis |
|
Benzene |
4.27 | 15902427 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.17 | 18249437 |
MESH:D003920 |
Diabetes Mellitus |
|
Sodium Selenite |
3.35 | 16285004 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
Cyclophosphamide |
7.30 | 11751995 15331540 10990075 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
resveratrol |
7.30 | 16873680 |
MESH:D003922 |
Diabetes Mellitus, Type 1 |
|
Cyclophosphamide |
3.05 | 18772604 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Genistein |
3.83 | 16647724 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
3.83 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
resveratrol |
3.54 | 16286809 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetaminophen |
7.51 | 17562736 12705907 19370779 19085960 19164858 15968718 16393943 11287661 16485898 19739265 2444490 14986274 12153990 16081117 11421492 10915739 12540782 18071297 12594235 16109766 10663392 11834606 14550746 17906064 19923254 16227642 10774834 16177239 11529661 14725611 15619225 18713872 17522070 11461765 19420014 16781746 12958197 11743745 12392966 11739529 19416960 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Dimethylnitrosamine |
7.51 | 8172417 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Sodium Selenite |
7.51 | 15131321 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
7.51 | 20420201 |
MESH:D056487 |
Drug-Induced Liver Injury, Chronic |
|
Acetaminophen |
3.58 | 19426721 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.38 | 11462148 |
MESH:D004417 |
Dyspnea |
|
Chlorine |
4.11 | 20016425 |
MESH:C538011 |
Eales disease |
|
Vitamin E |
4.19 | 9068938 |
MESH:D004487 |
Edema |
|
pirinixic acid |
8.84 | 12083418 |
MESH:D004487 |
Edema |
|
resveratrol |
8.84 | 8985016 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
8.84 | 12711302 11000095 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
3.38 | 15322242 18230668 16714409 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Calcitriol |
12.63 | 15138306 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
12.63 | 12538720 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
resveratrol |
12.63 | 17872969 |
MESH:D004714 |
Endometrial Hyperplasia |
|
Diethylstilbestrol |
10.20 | 16402032 |
MESH:D004714 |
Endometrial Hyperplasia |
|
Genistein |
10.20 | 16402032 |
MESH:D016889 |
Endometrial Neoplasms |
|
Diethylstilbestrol |
6.54 | 15700306 16804899 |
MESH:D016889 |
Endometrial Neoplasms |
|
Genistein |
6.54 | 11473722 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
2.58 | 9294722 10568697 |
MESH:D020345 |
Enterocolitis, Necrotizing |
|
resveratrol |
4.35 | 17923197 |
MESH:D004802 |
Eosinophilia |
|
Cyclophosphamide |
3.73 | 11006010 |
MESH:D004938 |
Esophageal Neoplasms |
|
arsenic trioxide |
6.39 | 12903497 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
6.39 | 16530937 |
MESH:D004938 |
Esophageal Neoplasms |
|
Dimethylnitrosamine |
6.39 | 17016578 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
2.63 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
arsenic trioxide |
15.02 | 15073043 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
15.02 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
15.02 | 15345470 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
15.02 | 20131406 19236843 |
MESH:D052776 |
Female Urogenital Diseases |
|
Diethylstilbestrol |
3.33 | 16002989 16513791 15751030 16611131 16534752 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
2.96 | 11858732 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
6.85 | 12168785 12639820 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
6.85 | 20067830 |
MESH:D005706 |
Gallbladder Neoplasms |
|
arsenic trioxide |
3.78 | 16904648 |
MESH:D005739 |
Gas Poisoning |
|
Chlorine |
4.49 | 20016425 |
MESH:D005756 |
Gastritis |
|
Acetaminophen |
3.16 | 16983495 |
MESH:D005833 |
Genital Neoplasms, Female |
|
Diethylstilbestrol |
4.44 | 16452187 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
3.71 | 8708960 |
MESH:D005909 |
Glioblastoma |
|
Genistein |
2.92 | 16598420 |
MESH:D018316 |
Gliosarcoma |
|
Cyclophosphamide |
5.00 | 11389073 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.08 | 10696789 |
MESH:D006086 |
Graft vs Host Disease |
|
Cyclophosphamide |
4.54 | 15172196 11014644 16376943 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
9.43 | 20471113 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
9.43 | 11294989 10048152 |
MESH:D006330 |
Heart Defects, Congenital |
|
Vitamin E |
9.43 | 16080930 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.21 | 20558911 |
MESH:D016481 |
Helicobacter Infections |
|
Malondialdehyde |
5.50 | 17278206 |
MESH:D006390 |
Hemangioendothelioma |
|
quinoline |
5.39 | 598648 |
MESH:D006394 |
Hemangiosarcoma |
|
quinoline |
4.54 | 598648 |
MESH:D006402 |
Hematologic Diseases |
|
Benzene |
4.19 | 16183116 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
3.91 | 15720958 |
MESH:D006467 |
Hemophilia A |
|
Cyclophosphamide |
4.79 | 11918545 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
2.88 | 11000095 |
MESH:D006504 |
Hepatic Veno-Occlusive Disease |
|
Cyclophosphamide |
5.02 | 14986274 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
6.63 | 18467677 16221962 19772884 19176532 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
6.63 | 15340226 12621046 16120746 |
MESH:D006548 |
Hernia, Diaphragmatic |
|
Vitamin E |
2.51 | 16490937 16863852 |
MESH:D006561 |
Herpes Simplex |
|
resveratrol |
3.68 | 16876885 |
MESH:D006689 |
Hodgkin Disease |
|
Cyclophosphamide |
3.37 | 17606976 16135485 |
MESH:D019584 |
Hot Flashes |
|
Vitamin E |
3.46 | 14716179 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.53 | 16354765 15340226 18606429 8697196 16959395 |
MESH:D006930 |
Hyperalgesia |
|
Acetaminophen |
2.30 | 16870215 |
MESH:D006937 |
Hypercholesterolemia |
|
resveratrol |
3.55 | 17188708 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
2.74 | 20558911 |
MESH:D006949 |
Hyperlipidemias |
|
resveratrol |
3.56 | 16873680 |
MESH:D006965 |
Hyperplasia |
|
Diethylstilbestrol |
3.94 | 14722030 12960047 |
MESH:D006973 |
Hypertension |
|
Benzene |
7.33 | 17940673 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
7.33 | 10903974 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
7.33 | 18670907 18850075 |
MESH:D017379 |
Hypertrophy, Left Ventricular |
|
resveratrol |
3.86 | 17488730 |
MESH:D007021 |
Hypospadias |
|
Diethylstilbestrol |
9.59 | 16002989 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
9.59 | 16569931 16945680 |
MESH:D007154 |
Immune System Diseases |
|
Cyclophosphamide |
4.81 | 16076520 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
resveratrol |
4.15 | 17600658 |
MESH:D007246 |
Infertility |
|
Diethylstilbestrol |
3.87 | 15036965 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
2.99 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
Atrazine |
9.36 | 12948887 |
MESH:D007248 |
Infertility, Male |
|
Cyclophosphamide |
9.36 | 16517039 7193160 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
9.36 | 17937319 |
MESH:D007249 |
Inflammation |
|
resveratrol |
4.14 | 16366677 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
4.14 | 12200463 12878042 |
MESH:D007251 |
Influenza, Human |
|
resveratrol |
9.37 | 16624496 |
MESH:D007251 |
Influenza, Human |
|
Vitamin E |
9.37 | 16624496 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
6.17 | 16306350 |
MESH:D007333 |
Insulin Resistance |
|
Sodium Selenite |
6.17 | 14714311 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
2.88 | 16580747 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
3.92 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Acetaminophen |
8.21 | 15629191 12587719 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
8.21 | 8314463 10903974 18776723 |
MESH:D007674 |
Kidney Diseases |
|
Vitamin E |
8.21 | 12488133 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Malondialdehyde |
5.40 | 16518626 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
6.08 | 12371664 |
MESH:D007680 |
Kidney Neoplasms |
|
Diethylstilbestrol |
6.08 | 15003126 14681315 16762066 |
MESH:D007683 |
Kidney Tubular Necrosis, Acute |
|
Calcium |
4.53 | 16316344 |
MESH:D007859 |
Learning Disorders |
|
Diethylstilbestrol |
3.57 | 17184923 |
MESH:D007938 |
Leukemia |
|
arsenic trioxide |
12.76 | 15070760 |
MESH:D007938 |
Leukemia |
|
Benzene |
12.76 | 18335105 17119257 14694614 15935818 |
MESH:D007938 |
Leukemia |
|
Cyclophosphamide |
12.76 | 10602166 |
MESH:D007938 |
Leukemia |
|
Genistein |
12.76 | 18980019 17468513 |
MESH:D015451 |
Leukemia, Lymphocytic, Chronic, B-Cell |
|
Cyclophosphamide |
3.26 | 17296974 17802794 17658394 18587576 17008537 18172266 |
MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
arsenic trioxide |
3.34 | 17077332 12560223 |
MESH:D007948 |
Leukemia, Monocytic, Acute |
|
arsenic trioxide |
3.80 | 16972261 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
arsenic trioxide |
7.35 | 14633726 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
Cyclophosphamide |
7.35 | 10373061 |
MESH:D007951 |
Leukemia, Myeloid |
|
arsenic trioxide |
8.19 | 19077051 |
MESH:D007951 |
Leukemia, Myeloid |
|
Benzene |
8.19 | 17506065 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
arsenic trioxide |
3.73 | 17050201 20471514 16968895 16467208 19850784 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Benzene |
3.73 | 19478238 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
arsenic trioxide |
6.64 | 15748426 15213294 16966277 17712046 16112521 16891316 16331271 9834237 19225113 12712474 12018890 16823087 15336539 19035177 19642359 17649720 11468182 17869043 17217047 15622746 11161223 19075265 17107899 12679006 16330433 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
resveratrol |
6.64 | 16087638 |
MESH:D015458 |
Leukemia, T-Cell |
|
arsenic trioxide |
3.87 | 16882451 |
MESH:D007970 |
Leukopenia |
|
Cyclophosphamide |
4.46 | 11830472 10052129 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Dimethylnitrosamine |
5.88 | 15298665 15744066 14709902 15723089 17881167 16603200 14659978 14726149 17719030 18637143 15479170 15591649 18237412 18567088 17348192 15369754 15339415 14643895 15492853 17203207 15733078 16009107 15842777 16169303 17534399 17724770 18210741 15383259 15138612 17201889 12918455 15577212 15161499 16570917 16042886 17198567 15099470 15571005 16270385 15504291 18095165 18629640 16544323 18239293 15366600 15793283 12925901 18364076 15067225 17432682 18371158 15763062 15086199 15081153 17666798 14568256 17196135 16627068 15942678 17465448 15864749 17036385 15798949 17640959 18672772 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Genistein |
5.88 | 17823541 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
5.88 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
5.88 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Vitamin E |
5.88 | 16169303 |
MESH:D008107 |
Liver Diseases |
|
Acetaminophen |
1.50 | 12969438 16611625 19784758 12587719 16610002 11587558 19014921 19460945 |
MESH:D017114 |
Liver Failure, Acute |
|
Acetaminophen |
8.20 | 16871587 17185352 |
MESH:D017114 |
Liver Failure, Acute |
|
Dimethylnitrosamine |
8.20 | 17457977 |
MESH:D008113 |
Liver Neoplasms |
|
2-nitrofluorene |
37.59 | 15890375 |
MESH:D008113 |
Liver Neoplasms |
|
4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone |
37.59 | 15890375 |
MESH:D008113 |
Liver Neoplasms |
|
Aflatoxin B1 |
37.59 | 15890375 2125692 18177683 9163691 |
MESH:D008113 |
Liver Neoplasms |
|
arsenic trioxide |
37.59 | 14682389 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
37.59 | 21137059 20195826 |
MESH:D008113 |
Liver Neoplasms |
|
Diethylstilbestrol |
37.59 | 16712894 15890375 |
MESH:D008113 |
Liver Neoplasms |
|
Dimethylnitrosamine |
37.59 | 15890375 3113478 |
MESH:D008113 |
Liver Neoplasms |
|
Methapyrilene |
37.59 | 15890375 |
MESH:D008113 |
Liver Neoplasms |
|
Piperonyl Butoxide |
37.59 | 20101389 19690152 15890375 18648771 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
37.59 | 16377806 20007298 15890375 |
MESH:D008113 |
Liver Neoplasms |
|
resveratrol |
37.59 | 19812893 19321006 20405173 19073162 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
37.59 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Aflatoxin B1 |
15.16 | 8603461 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
arsenic trioxide |
15.16 | 20377131 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Benzene |
15.16 | 12562636 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Dimethylnitrosamine |
15.16 | 6150874 15603536 1848544 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
15.16 | 12151625 |
MESH:D008133 |
Long QT Syndrome |
|
arsenic trioxide |
2.96 | 15213294 |
MESH:D008171 |
Lung Diseases |
|
chromium hexavalent ion |
10.52 | 16775837 |
MESH:D008171 |
Lung Diseases |
|
Ozone |
10.52 | 19066396 8266340 |
MESH:D008171 |
Lung Diseases |
|
Vitamin E |
10.52 | 16863852 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Benzene |
4.29 | 14698565 |
MESH:D055370 |
Lung Injury |
|
Ozone |
3.36 | 20417186 |
MESH:D008175 |
Lung Neoplasms |
|
4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone |
18.55 | 14755239 16401635 15893417 15172992 19931552 9255578 18508827 17139156 12438228 16061637 18813816 |
MESH:D008175 |
Lung Neoplasms |
|
Acetaldehyde |
18.55 | 17372256 |
MESH:D008175 |
Lung Neoplasms |
|
Aflatoxin B1 |
18.55 | 14755239 |
MESH:D008175 |
Lung Neoplasms |
|
arsenic trioxide |
18.55 | 11798837 19825857 |
MESH:D008175 |
Lung Neoplasms |
|
Benzene |
18.55 | 12562636 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
18.55 | 18569708 18520028 20464547 20869020 20135361 20064080 6695378 17053015 18816296 |
MESH:D008175 |
Lung Neoplasms |
|
chromium hexavalent ion |
18.55 | 16570259 16876463 |
MESH:D008175 |
Lung Neoplasms |
|
Dimethylnitrosamine |
18.55 | 19555203 11884234 16061637 |
MESH:D008175 |
Lung Neoplasms |
|
Ozone |
18.55 | 8597069 7614698 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
18.55 | 19555203 11884234 |
MESH:D008175 |
Lung Neoplasms |
|
Vitamin E |
18.55 | 11062179 |
MESH:D008181 |
Lupus Nephritis |
|
Diethylstilbestrol |
4.64 | 15166399 |
MESH:D008223 |
Lymphoma |
|
Benzene |
10.58 | 17584886 17119257 |
MESH:D008223 |
Lymphoma |
|
Cyclophosphamide |
10.58 | 12854902 |
MESH:D008223 |
Lymphoma |
|
Diethylstilbestrol |
10.58 | 15700306 |
MESH:D016393 |
Lymphoma, B-Cell |
|
Cyclophosphamide |
14.50 | 16675587 |
MESH:D016393 |
Lymphoma, B-Cell |
|
resveratrol |
14.50 | 17088997 |
MESH:D016393 |
Lymphoma, B-Cell |
|
Sodium Selenite |
14.50 | 14737004 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Cyclophosphamide |
7.64 | 11911406 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
resveratrol |
7.64 | 14749477 |
MESH:D052801 |
Male Urogenital Diseases |
|
Diethylstilbestrol |
5.00 | 16002989 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
Benzene |
8.57 | 12562636 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
resveratrol |
8.57 | 15688416 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Benzene |
8.19 | 11921183 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Genistein |
8.19 | 14578162 12929590 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
resveratrol |
8.19 | 8985016 11606380 |
MESH:D008545 |
Melanoma |
|
6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid |
3.73 | 17992120 |
MESH:D008545 |
Melanoma |
|
resveratrol |
3.73 | 17992120 |
MESH:D008546 |
Melanoma, Experimental |
|
Acetaminophen |
9.18 | 19513568 |
MESH:D008546 |
Melanoma, Experimental |
|
Cyclophosphamide |
9.18 | 16388313 |
MESH:D008569 |
Memory Disorders |
|
Methylmercury Compounds |
4.43 | 18436314 |
MESH:D008654 |
Mesothelioma |
|
Atrazine |
3.31 | 1916698 |
MESH:D008659 |
Metabolic Diseases |
|
resveratrol |
3.92 | 17112576 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.27 | 16801185 |
MESH:D008679 |
Metaplasia |
|
Ozone |
4.59 | 10496685 |
MESH:D009041 |
Motion Sickness |
|
Dextroamphetamine |
5.00 | 1613127 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
2.80 | 16381670 |
MESH:D009069 |
Movement Disorders |
|
Methylmercury Compounds |
4.86 | 18436314 |
MESH:D009101 |
Multiple Myeloma |
|
arsenic trioxide |
10.08 | 11468182 19417148 14977855 15949261 19549372 |
MESH:D009101 |
Multiple Myeloma |
|
Benzene |
10.08 | 17119195 |
MESH:D009101 |
Multiple Myeloma |
|
resveratrol |
10.08 | 14749477 17049120 16267019 16490592 17935668 17164350 |
MESH:D009134 |
Muscular Atrophy, Spinal |
|
resveratrol |
4.36 | 17962980 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.01 | 16239165 |
MESH:D009182 |
Mycosis Fungoides |
|
arsenic trioxide |
4.15 | 18349030 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
arsenic trioxide |
2.84 | 16105982 16882451 |
MESH:D009203 |
Myocardial Infarction |
|
Genistein |
8.12 | 17141266 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
8.12 | 19151258 |
MESH:D009203 |
Myocardial Infarction |
|
resveratrol |
8.12 | 16525036 17125593 16456233 16317513 17015251 17188708 |
MESH:D017202 |
Myocardial Ischemia |
|
resveratrol |
7.66 | 17125593 17015251 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
7.66 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Genistein |
7.08 | 17141266 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
7.08 | 16411023 |
MESH:D009205 |
Myocarditis |
|
resveratrol |
4.25 | 17322642 |
MESH:D009361 |
Neoplasm Invasiveness |
|
arsenic trioxide |
3.48 | 16624393 |
MESH:D009362 |
Neoplasm Metastasis |
marker/mechanism |
|
| 20562527 |
MESH:D009362 |
Neoplasm Metastasis |
|
quinoline |
3.83 | 598648 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
9.64 | 11141357 |
MESH:D009369 |
Neoplasms |
|
Cyclophosphamide |
9.64 | 18854779 |
MESH:D009369 |
Neoplasms |
|
Diethylstilbestrol |
9.64 | 15313581 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
9.64 | 17405874 |
MESH:D009374 |
Neoplasms, Experimental |
|
resveratrol |
3.51 | 8985016 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
3.92 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
2.86 | 18481113 19348381 |
MESH:D009421 |
Nervous System Malformations |
|
Diethylstilbestrol |
13.64 | 11399458 |
MESH:D009421 |
Nervous System Malformations |
|
Genistein |
13.64 | 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
13.64 | 14600291 |
MESH:D009436 |
Neural Tube Defects |
|
arsenic trioxide |
6.39 | 10525206 |
MESH:D009436 |
Neural Tube Defects |
|
Benzene |
6.39 | 15643154 |
MESH:D009447 |
Neuroblastoma |
|
Cyclophosphamide |
3.36 | 15176712 16115947 8761367 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Acetaminophen |
6.97 | 18514411 |
MESH:D019636 |
Neurodegenerative Diseases |
|
resveratrol |
6.97 | 17652729 |
MESH:D017599 |
Neuroectodermal Tumors |
|
Cyclophosphamide |
4.38 | 12837982 8761367 |
MESH:D020078 |
Neurogenic Inflammation |
|
resveratrol |
3.93 | 17929310 |
MESH:D009503 |
Neutropenia |
|
Cyclophosphamide |
3.86 | 8291058 |
MESH:D009669 |
Nose Neoplasms |
|
chromium hexavalent ion |
4.61 | 16876463 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.67 | 20558911 |
MESH:D009784 |
Occupational Diseases |
|
Benzene |
3.74 | 15913788 15576619 15935809 17119257 17178637 15612468 17479406 15727169 16737584 |
MESH:D009845 |
Oligospermia |
|
Cyclophosphamide |
4.21 | 16517039 |
MESH:D010024 |
Osteoporosis |
|
Calcium |
6.39 | 17882678 |
MESH:D010024 |
Osteoporosis |
|
Genistein |
6.39 | 19401787 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Genistein |
8.60 | 16169203 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
resveratrol |
8.60 | 17513867 |
MESH:D010051 |
Ovarian Neoplasms |
|
arsenic trioxide |
9.83 | 16624393 19769630 12452020 |
MESH:D010051 |
Ovarian Neoplasms |
|
Benzene |
9.83 | 12562636 |
MESH:D010051 |
Ovarian Neoplasms |
|
CD 437 |
9.83 | 17474084 |
MESH:D010051 |
Ovarian Neoplasms |
|
Genistein |
9.83 | 19005980 |
MESH:D010146 |
Pain |
|
Acetaminophen |
5.50 | 16870215 |
MESH:D010146 |
Pain |
|
Cyclophosphamide |
5.50 | 12161096 18093676 |
MESH:D010190 |
Pancreatic Neoplasms |
|
4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone |
7.63 | 12384795 |
MESH:D010190 |
Pancreatic Neoplasms |
|
arsenic trioxide |
7.63 | 15580305 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Cyclophosphamide |
7.63 | 11332152 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.22 | 11578682 |
MESH:D010212 |
Papilloma |
|
cumene hydroperoxide |
4.84 | 12065085 17234724 |
MESH:D010235 |
Paraganglioma |
|
arsenic trioxide |
3.69 | 19927285 |
MESH:D010300 |
Parkinson Disease |
|
Atrazine |
3.07 | 17218051 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
3.73 | 12520081 |
MESH:D010538 |
Peritonitis |
|
Ozone |
3.64 | 16369182 |
MESH:D010787 |
Photosensitivity Disorders |
|
4-hydroxy-2-nonenal |
4.98 | 11550810 |
MESH:D010900 |
Pituitary Diseases |
|
Diethylstilbestrol |
4.65 | 14722030 |
MESH:D010911 |
Pituitary Neoplasms |
|
Diethylstilbestrol |
4.17 | 15687265 16977796 |
MESH:D011014 |
Pneumonia |
|
Ozone |
3.89 | 18007984 18929643 18381685 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.08 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
2.80 | 12371664 |
MESH:D054198 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma |
|
Cyclophosphamide |
3.50 | 21297632 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Diethylstilbestrol |
19.16 | 17184923 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Methylmercury Compounds |
19.16 | 18436314 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
resveratrol |
19.16 | 16679765 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
19.16 | 11222880 11118676 11399792 11896295 |
MESH:D011470 |
Prostatic Hyperplasia |
|
Calcitriol |
4.27 | 15572423 |
MESH:D011471 |
Prostatic Neoplasms |
|
arsenic trioxide |
2.72 | 19131511 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
2.72 | 17292933 |
MESH:D011471 |
Prostatic Neoplasms |
|
Calcitriol |
2.72 | 12479363 18247401 15754350 16289102 16644109 |
MESH:D011471 |
Prostatic Neoplasms |
|
Cyclophosphamide |
2.72 | 17136230 |
MESH:D011471 |
Prostatic Neoplasms |
|
Diethylstilbestrol |
2.72 | 15046698 17136230 15846301 |
MESH:D011471 |
Prostatic Neoplasms |
|
Genistein |
2.72 | 16925846 15378649 15256057 |
MESH:D011471 |
Prostatic Neoplasms |
|
resveratrol |
2.72 | 16731767 17636462 15767336 17804756 17718901 17675339 |
MESH:D011471 |
Prostatic Neoplasms |
|
Sodium Selenite |
2.72 | 18760546 |
MESH:D011471 |
Prostatic Neoplasms |
|
Vitamin E |
2.72 | 15084515 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
2.81 | 16919318 15861022 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.03 | 16882103 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Cyclophosphamide |
3.07 | 16636934 |
MESH:D051436 |
Renal Insufficiency, Chronic |
|
resveratrol |
5.06 | 16325855 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
5.67 | 19058328 |
MESH:D015427 |
Reperfusion Injury |
|
resveratrol |
5.67 | 16314181 17058453 17520802 15827377 16317513 |
MESH:D012120 |
Respiration Disorders |
|
Chlorine |
4.69 | 18579056 |
MESH:D012135 |
Respiratory Sounds |
|
Atrazine |
4.02 | 11874814 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.35 | 18990726 |
MESH:D012220 |
Rhinitis |
|
Acetaldehyde |
4.31 | 17050345 |
MESH:D012512 |
Sarcoma, Ewing's |
|
arsenic trioxide |
3.48 | 16646077 |
MESH:D012595 |
Scleroderma, Systemic |
|
Cyclophosphamide |
4.35 | 16636934 |
MESH:D012871 |
Skin Diseases |
|
Vitamin E |
2.29 | 18709164 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
15.17 | 19755658 10029692 |
MESH:D012878 |
Skin Neoplasms |
|
cumene hydroperoxide |
15.17 | 12065085 8532709 17234724 |
MESH:D012878 |
Skin Neoplasms |
|
resveratrol |
15.17 | 8985016 15837718 |
MESH:D012878 |
Skin Neoplasms |
|
tert-Butylhydroperoxide |
15.17 | 8532709 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
15.17 | 16192470 |
MESH:D013088 |
Spermatocele |
|
Diethylstilbestrol |
9.99 | 16002989 16709447 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
9.99 | 16709447 |
OMIM:102530 |
SPERMATOGENIC FAILURE 6 |
|
Cyclophosphamide |
5.00 | 16517039 |
MESH:D013158 |
Splenic Diseases |
|
Dimethylnitrosamine |
4.75 | 12587719 |
MESH:D013274 |
Stomach Neoplasms |
|
arsenic trioxide |
4.24 | 17007042 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzene |
4.24 | 12562636 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
4.24 | 20155912 2093021 |
MESH:D013274 |
Stomach Neoplasms |
|
Dimethylnitrosamine |
4.24 | 16033868 |
MESH:D020521 |
Stroke |
|
Vitamin E |
3.12 | 16517955 |
OMIM:601367 |
STROKE, ISCHEMIC |
|
resveratrol |
4.04 | 16321402 |
MESH:D015173 |
Supratentorial Neoplasms |
|
Cyclophosphamide |
4.55 | 12837982 |
MESH:D013733 |
Testicular Diseases |
|
phenethyl isothiocyanate |
4.44 | 15864552 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.15 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
2.73 | 15669648 |
MESH:D013953 |
Thymus Neoplasms |
|
Benzene |
4.45 | 10850423 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.38 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
arsenic trioxide |
2.71 | 19014326 |
MESH:D014062 |
Tongue Neoplasms |
|
resveratrol |
3.77 | 16227395 |
MESH:D016171 |
Torsades de Pointes |
|
arsenic trioxide |
3.46 | 15213294 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
arsenic trioxide |
13.44 | 12845720 20435036 12973940 11780464 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
13.44 | 17053015 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
CD 437 |
13.44 | 16720286 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Cyclophosphamide |
13.44 | 14692829 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Diethylstilbestrol |
13.44 | 17306315 16712894 16452187 |
MESH:D014581 |
Urticaria |
|
Acetaminophen |
2.51 | 10982225 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Diethylstilbestrol |
8.20 | 16175088 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
resveratrol |
8.20 | 17473185 |
MESH:D014591 |
Uterine Diseases |
|
Diethylstilbestrol |
4.65 | 14652134 |
MESH:D014594 |
Uterine Neoplasms |
|
Benzene |
18.97 | 12562636 |
MESH:D014594 |
Uterine Neoplasms |
|
Diethylstilbestrol |
18.97 | 15809267 16690809 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
18.97 | 14692618 |
MESH:D014594 |
Uterine Neoplasms |
|
resveratrol |
18.97 | 17044934 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
3.47 | 1336536 |
MESH:D014625 |
Vaginal Neoplasms |
|
Diethylstilbestrol |
3.94 | 16513791 16002989 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.08 | 12125929 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.08 | 14671159 15869587 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
resveratrol |
3.81 | 17488730 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
3.73 | 15886252 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
3.92 | 17120751 |